<DOC>
	<DOC>NCT02613169</DOC>
	<brief_summary>Randomized controlled trial (RCT) of isoniazid (INH) vs. no INH to prevent Mycobacterium tuberculosis infection in HIV-exposed uninfected (HEU) infants.</brief_summary>
	<brief_title>Infant TB Infection Prevention Study</brief_title>
	<detailed_description>The purpose of this trial is to determine whether isoniazid (INH) reduces the risk of Mycobacterium tuberculosis (MTB) infection in HIV-exposed but uninfected (HEU) children, as well as to determine epidemiologic and immunologic correlates of MTB infection in HEU.</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Isoniazid</mesh_term>
	<criteria>HIV exposed infants Aged 6 weeks within (+ 4 weeks) Born to HIVinfected mothers Not premature and over 2.5 kg Infants with known exposure to active TB in household Premature and &lt; 2.5 kg</criteria>
	<gender>All</gender>
	<minimum_age>6 Weeks</minimum_age>
	<maximum_age>10 Weeks</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>M. tuberculosis infection</keyword>
	<keyword>isoniazid</keyword>
	<keyword>HIV-exposed infants</keyword>
</DOC>